[go: up one dir, main page]

KR880000091A - 국소용 약제학적 조성물 이의 제조방법 및 이의 용도 - Google Patents

국소용 약제학적 조성물 이의 제조방법 및 이의 용도 Download PDF

Info

Publication number
KR880000091A
KR880000091A KR870005609A KR870005609A KR880000091A KR 880000091 A KR880000091 A KR 880000091A KR 870005609 A KR870005609 A KR 870005609A KR 870005609 A KR870005609 A KR 870005609A KR 880000091 A KR880000091 A KR 880000091A
Authority
KR
South Korea
Prior art keywords
pharmaceutical composition
active ingredient
composition according
pharmaceutically acceptable
treatment
Prior art date
Application number
KR870005609A
Other languages
English (en)
Inventor
뵈춰 이름가르트
피그나트 베르너
Original Assignee
칼에프. 조르다
시바 가이기 코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 칼에프. 조르다, 시바 가이기 코포레이션 filed Critical 칼에프. 조르다
Publication of KR880000091A publication Critical patent/KR880000091A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음

Description

국소용 약제학적 조성물 이의 제조방법 및 이의 용도
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (11)

  1. 통상의 약제학적 보조제와 함께, 활성 성분으로서 하기구조식(I)의 화합물 또는 이의 약제학적으로 허용되는 염중의 하나를 함유함을 특징으로 하는, 국소용, 즉 피부용 약제학적 조성물.
  2. 제 1 항에 있어서, 크림제, 연고제, 지방성 연고제, 페이스트, 겔제, 포움제, 팅크제, 용액제 또는 점안제 형태인 약제학적 조성물.
  3. 하기 구조식(I)의 화합물 또는 이의 약제학적으로 허용되는 염중의 하나를, 특히 제 1 항 또는 2 항에 따르는 약제학적 조성물의 형태로, 국소적으로, 즉 피부에 적용함을 특징으로 하여, 염증성 피부 질환을 치료하는 방법.
  4. 염증성 피부 질환을 국소적, 즉 피부적으로 치료하기 위한, 하기 구조식(I)의 화합물 또는 이의 약제학적으로 허용되는 염중 하나의 용도.
  5. 염증성 피부 질환을 국소적, 즉 피부적으로 치료하도록 의도면 피부과용 약제학적 조성물을 제조하기 위한, 하기 구조식(I)의 화합물 또는 이의 약제학적으로 허용되는 염중 하나의 용도.
  6. 활성 성분으로 2-하이드록시-5-[(RS)-1하이드록시-2-[[(RS)-1-(P-메톡시페닐)-프로프-2-일]-아미노]-에틸]-포름아닐라이드(포름오테롤) 또는 이의 약제학적으로 허용되는 염이 선택됨을 특징으로 하는, 제 1 항 또는 2 항에 따르는 약제학적 조성물, 제 3 항에 따르는 치료 방법 및 제 4 항 또는 5 항에 따르는 용도.
  7. 활성 성분으로서 2-하이드록시-5-[(RS)-1하이드록시-2-[[(RS)-1-(P-메톡시페닐)-프로프-2-일]-아미노]-에틸]-포름아닐라이드(포름오테롤) 또는 이의 세미푸마레이트가 선택됨을 특징으로 하는, 제 1 항 또는 제 2 항에 따르는 약제학적 조성물, 제 3 항에 따르는 치료방법 및 제 4 항 또는 5 항에 따르는 용도.
  8. 활성 성분의 이율이 대략 0.00001 내지 1중량 %임을 특징으로 하는, 제 1,2,6 및 7항 중 어느 한항에 따르는 약제학적 조성물, 제 3,6 및 7항 중 어느 한 항에 따르는 치료방법 및 제 4 내지 7항중 어느 한 항에 따르는 용도.
  9. 활성 성분의 비율이 대략 0.0005 내지 0.5중량 %임을 특징으로 하는, 제 1,2,6 및 7항 중 어느 한항에 따르는 약제학적 조성물, 제 3,6 및 7항중 어느 한 항에 따르는 치료 방법 및 제 4 내지 7항 중 어느 한 항에 따르는 용도.
  10. 제 3,6 및 7 항중 어느 한 항에 있어서, 치료할 피부 부위를 1일 2 또는 3회 치료함을 특징으로하는 치료 방법.
  11. 제 1,2 및 6내지 9항 중 어느 한 항에 있어서, 실시예 1내지 9에 기술된 바와 같은 약제학적 조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR870005609A 1986-06-05 1987-06-03 국소용 약제학적 조성물 이의 제조방법 및 이의 용도 KR880000091A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH2290/86-4 1986-06-05
CH229086 1986-06-05

Publications (1)

Publication Number Publication Date
KR880000091A true KR880000091A (ko) 1988-03-23

Family

ID=4230316

Family Applications (1)

Application Number Title Priority Date Filing Date
KR870005609A KR880000091A (ko) 1986-06-05 1987-06-03 국소용 약제학적 조성물 이의 제조방법 및 이의 용도

Country Status (10)

Country Link
US (1) US4975466A (ko)
EP (1) EP0252286B1 (ko)
JP (1) JPS6322015A (ko)
KR (1) KR880000091A (ko)
AU (1) AU614712B2 (ko)
CA (1) CA1305423C (ko)
DE (1) DE3780226D1 (ko)
DK (1) DK167841B1 (ko)
IE (1) IE59612B1 (ko)
PH (1) PH25150A (ko)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0416925A3 (en) * 1989-09-07 1991-09-25 Glaxo Group Limited Use of 4-hydroxy-alpha 1-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-1,3-benzenedimethanol or its salts in the treatment of allergy and inflammation
US5434304A (en) * 1990-09-26 1995-07-18 Aktiebolaget Astra Process for preparing formoterol and related compounds
US6299863B1 (en) 1992-04-03 2001-10-09 Sepracor Inc. Aerosol formulations containing micronized optically pure (R,R) formoterol for bronchodilating therapy
US6866839B2 (en) * 1991-04-05 2005-03-15 Sepracor Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
US5795564A (en) * 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
US5135954A (en) * 1991-05-24 1992-08-04 The Regents Of The University Of California Use of formoterol for treatment of tissue injury
AU7639796A (en) * 1995-11-30 1997-06-19 Kissei Pharmaceutical Co. Ltd. Novel drug for relieving pain and promoting the removal of calculi in urolithiasis
CN1232389A (zh) * 1996-10-04 1999-10-20 崎玉第一制药株式会社 贴剂
US6319464B1 (en) 1996-12-13 2001-11-20 Alcon Manufacturing, Ltd. Use of low molecular weight amino alcohols in ophthalmic compositions
US6303145B2 (en) 1999-05-10 2001-10-16 Sepracor Inc. (S,R) formoterol methods and compositions
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US20060140984A1 (en) 2002-10-25 2006-06-29 Foamix Ltd. Cosmetic and pharmaceutical foam
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9211259B2 (en) * 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
JP5108234B2 (ja) * 2005-02-07 2012-12-26 日本特殊陶業株式会社 マイクロヒータ及びセンサ
ES2348920T3 (es) 2005-04-13 2010-12-17 Astion Development A/S Agonistas de adrenoceptores beta-2 para el tratamiento de enfermedades del tejido conectivo de la piel.
US9023863B2 (en) * 2006-07-14 2015-05-05 Stiefel Research Australia Pty Ltd Fatty acid pharmaceutical foam
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
CA2712120A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
WO2010091274A1 (en) * 2009-02-06 2010-08-12 Skinvisible Pharmaceuticals, Inc. A cationic pharmaceutically active ingredient containing composition, and methods for manufacturing and using
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011064631A1 (en) 2009-10-02 2011-06-03 Foamix Ltd. Surfactant-free, water-free, foamable compositions and breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US8174881B2 (en) 2009-11-24 2012-05-08 Micron Technology, Inc. Techniques for reducing disturbance in a semiconductor device
CA2978573A1 (en) 2016-09-08 2018-03-08 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2366625C2 (ko) * 1972-02-05 1988-06-09 Yamanouchi Pharmaceutical Co., Ltd., Tokio/Tokyo, Jp
US3994974A (en) * 1972-02-05 1976-11-30 Yamanouchi Pharmaceutical Co., Ltd. α-Aminomethylbenzyl alcohol derivatives
DE2401450A1 (de) * 1973-01-16 1974-07-18 John James Voorhees Pharmazeutische zusammensetzung zur linderung von hautproliferationserkrankungen
GB1531718A (en) * 1974-11-20 1978-11-08 Pharmacia As Phenylethanolamines
DK31578A (da) * 1977-02-03 1978-08-04 Allen & Hanburys Ltd Fremgangsmaade til fremstilling af benzenderivater
JPS5592312A (en) * 1978-12-29 1980-07-12 Yamanouchi Pharmaceut Co Ltd Suppository containing bronchodilating compound
US4303637A (en) * 1980-04-04 1981-12-01 Alza Corporation Medication indicated for ocular hypertension
JPS56140915A (en) * 1980-04-07 1981-11-04 Yamanouchi Pharmaceut Co Ltd Pharmaceutical preparation for solid drug
JPS60174716A (ja) * 1984-02-21 1985-09-09 Yamanouchi Pharmaceut Co Ltd パツチ剤

Also Published As

Publication number Publication date
EP0252286A2 (de) 1988-01-13
AU7383687A (en) 1987-12-10
PH25150A (en) 1991-03-13
IE871485L (en) 1987-12-05
JPS6322015A (ja) 1988-01-29
IE59612B1 (en) 1994-03-09
DE3780226D1 (de) 1992-08-13
DK289487D0 (da) 1987-06-04
US4975466A (en) 1990-12-04
EP0252286B1 (de) 1992-07-08
DK167841B1 (da) 1993-12-27
CA1305423C (en) 1992-07-21
DK289487A (da) 1987-12-06
EP0252286A3 (en) 1990-01-17
AU614712B2 (en) 1991-09-12
JPH0448774B2 (ko) 1992-08-07

Similar Documents

Publication Publication Date Title
KR880000091A (ko) 국소용 약제학적 조성물 이의 제조방법 및 이의 용도
JP2668800B2 (ja) 皮膚疾患の局所治療
KR950014448B1 (ko) 소양증 치료를 위한 피부과용 약제 조성물
US4296130A (en) Methylsulfonylmethane and methods of use
US4607101A (en) Method of treating acne vulgaris with a composition containing carbamide peroxide
US4477469A (en) Preparations containing methylsulfonylmethane and methods of use and purification
US4301145A (en) Antiseptic skin cream
KR960000855A (ko) L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제조성물
JPS611623A (ja) 局所薬および全身薬の皮膚および膜を介する透過促進組成物およびその方法
KR900017590A (ko) 좌창(Acne)치료방법 및 그 약제 조성물
KR950000142A (ko) 피부질환치료용 약제조성물 제조에 사용되는 히드록시산함유 l-카르니틴에스테르 및 아실 l-카르니틴에스테르의 용도
DK284386A (da) Farmaceutisk praeparat mod hudlidelser
US6465514B1 (en) Methods and compositions for the promotion of hair growth
US3663716A (en) Method of treating acne with benzyl alcohol
US4518583A (en) Hemorrhoid and anorectal disease treatment method
KR950000141A (ko) 피부병 치료용 약제조성물 제조를 위한 방향족산을 함유한 l- 카르니틴 o-에스테르의 용도
KR960010003A (ko) L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제 조성물
KR880007068A (ko) 13-시스 레티노산의 용도
KR920700627A (ko) 치료제로서 1-페닐-2-아미노에탄올 유도체의 신규한 용도
IE810489L (en) Composition for topical application
GB2177917A (en) Dermatologically active substances
RU2005122466A (ru) Фармацевтические композиции, включающие комбинацию кальцитриола и клобетазола пропионат
US4994497A (en) Method of avoiding or minimizing burn damage to the skin
JPS60152415A (ja) 外用挫瘡治療剤
KR930701976A (ko) 알칸 아미도 암모늄 화합물의 신규용도

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19870603

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19920601

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19870603

Comment text: Patent Application

N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 19950127

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19950321

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 19950630

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 19950321

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I